Evaluation of Five Interleukin Genes for Association with End-Stage Renal Disease in White Europeans

American Journal of Nephrology

Volumn 32, Issue 2, 2010, Pages 103-108

  Buckham, Theresa A ^a   McKnight, Amy Jayne ^a   Benevente, David ^d   Courtney, Aisling E ^a   Patterson, Christopher C ^b   Simmonds, Matt ^b   Gough, Steven ^d   Middleton, Derek ^c   Borrows, Richard ^d   Maxwell, Alexander P ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

End stage renal disease; Interleukin; Polymorphism

Indexed keywords

CYTOKINE; IL10 PROTEIN, HUMAN; IL1A PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; IL1RN PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; EUROPEAN; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLOMERULONEPHRITIS; HUMAN; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; INTERLEUKIN 10 GENE; INTERLEUKIN 1ALPHA GENE; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; INTERLEUKIN GENE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CAUCASIAN; CHRONIC KIDNEY FAILURE; ETHNOLOGY; EUROPE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKINS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77953353733     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000314943     Document Type: Article

References (26)

1. US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Chapter 12: International Comparisons. 2009. www.usrds.org.
2. McKnight AJ, Currie D, Maxwell AP: Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders. J Pathol 2010; 220: 198-216.
3. McKnight AJ, O'Donoghue D, Maxwell AP: Annotated chromosome maps for renal disease. Hum Mutat 2009; 30: 314-320.
4. Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P: Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol 2004; 38: 405-416.
5. Kornman KS, Pankow J, Offenbacher S, Beck J, di Giovine F, Duff GW: Interleukin-1 genotypes and the association between periodontitis and cardiovascular disease. J Periodontal Res 1999; 34: 353-357.
6. Wetmore JB, Hung AM, Lovett DH, Sen S, Quershy O, Johansen KL: Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int 2005; 68: 278-284.
7. Loughrey BV, Maxwell AP, Fogarty DG, Middleton D, Harron JC, Patterson CC, Darke C, Savage DA: An interleukin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 1998; 10: 984-988.
8. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimburger O, Cederholm T, Girndt M: IL-10, IL- 6, and TNF-α: central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int 2005; 67: 1216-1233.
9. Ng DP, Nurbaya S, Ye SH, Krolewski AS: An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetic patients. Kidney Int 2008; 74: 521-527.
10. Mu W, Ouyang X, Agarwal A, Zhang L, Long DA, Cruz PE, Roncal CA, Glushakova OY, Chiodo VA, Atkinson MA, Hauswirth WW, Flotte TR, Rodriguez-Iturbe B, Johnson RJ: IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005; 16: 3651-3660.
11. Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C: IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 2006; 19: 50-56.
12. Manchanda PK, Singh R, Mittal RD: Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with endstage renal disease. DNA Cell Biol 2009; 28: 177-183.
13. Bensen JT, Langefeld CD, Hawkins GA, Green LE, Mychaleckyj JC, Brewer CS, Kiger DS, Binford SM, Colicigno CJ, Allred DC, Freedman BI, Bowden DW: Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster. Genomics 2003; 82: 194-217.
14. Buraczynska M, Jozwiak L, Ksiazek P, Borowicz E, Mierzicki P: Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Transl Res 2007; 150: 101-105.
15. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley- Brown D, Winkler CA, Smith MW, Parekh RS, Family Investigation of Nephropathy and Diabetes Research Group: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40: 1185-1192.
16. Dewberry R, Holden H, Crossman D, Francis S: Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol 2000; 20: 2394-2400.
17. Freedman BI, Yu H, Spray BJ, Rich SS, Rothschild CB, Bowden DW: Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int 1997; 51: 819-825.
18. Borgmann S, Endisch G, Hacker UT, Song BS, Fricke H: Proinflammatory genotype of interleukin-1 and interleukin-1 receptor antagonist is associated with ESRD in proteinase 3-ANCA vasculitis patients. Am J Kidney Dis 2003; 41: 933-942.
19. Blakemore AI, Cox A, Gonzalez AM, Maskil JK, Hughes ME, Wilson RM, Ward JD, Duff GW: Interleukin-1 receptor antagonist allele (IL1RN∗2) associated with nephropathy in diabetes mellitus. Hum Genet 1996; 97: 369-374.
20. Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD: Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-789.
21. Bensen JT, Langefeld CD, Li L, McCall CE, Cousart SL, Dryman BN, Freedman BI, Bowden DW: Association of an IL-1A 3′ UTR polymorphism with end-stage renal disease and IL-1 alpha expression. Kidney Int 2003; 63: 1211-1219.
22. Mittal RD, Manchanda PK: Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics 2007; 59: 159-165.
23. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T: Differential regulation of interleukin-10 production by genetic and environmental factors - a twin study. Genes Immun 2002; 3: 407-413.
24. Stenvinkel P, Pecoits-Filho R, Lindholm B, for the DialGene Consortium: Gene polymorphism association studies in dialysis: the nutrition-inflammation axis. Semin Dial 2005; 18: 322-330.
25. Liu Y, Berthier-Schaad Y, Fallin MD, Fink NE, Tracy RP, Klag MJ, Smith MW, Coresh J: IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 2006; 17: 863-870.
26. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ: Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002; 2: 560-567.